Regulation of Tendon Extracellular Matrix Assembly by the Fibroblast Surfaceome
成纤维细胞表面组对肌腱细胞外基质组装的调节
基本信息
- 批准号:8125115
- 负责人:
- 金额:$ 5.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAge-MonthsAnimalsBindingBinding SitesCell AdhesionCell Adhesion MoleculesCell membraneCell surfaceCellsClinical TreatmentCollagenCollagen FibrilComplexCytoskeletonDataDefectDetergentsDevelopmentEnvironmentExperimental DesignsExtracellular MatrixFiberFibroblast Growth Factor ReceptorsFibroblastsFibronectinsFlexorGeneticGoalsGrowth FactorGrowth Factor ReceptorsHealedHeparan Sulfate ProteoglycanHeparin BindingImmunohistochemistryImmunoprecipitationInflammationInjuryIntegrinsLinkMatrix MetalloproteinasesMembraneMembrane ProteinsMetalloproteasesMusMusculoskeletal DiseasesProteinsProteoglycanProteomicsProtocols documentationReceptor CellRecruitment ActivityRegulationRoleSignal TransductionSiteStagingStimulusStructureSurfaceTendinitisTendon InjuriesTendon structureWeight-Bearing stateWestern Blottingage relatedagedanimal extractbiglycancell motilitydecorinextracellularfibrillogenesisfibromodulingenetic regulatory proteinhealinginjuredlumicanmigrationmouse modelregenerativesyndecan
项目摘要
DESCRIPTION (provided by applicant): This proposal will focus on the tendon fibroblast surfaceome (the proteins on the tendon fibroblast surface) and its role in regulating collagen fibrillogenesis and extracellular matrix (ECM) assembly. Dysregulation of fibrillogenesis or assembly is associated with musculoskeletal disorders such as improper tendon formation, tendonitis and impaired tendon healing after injury. The general hypothesis of this proposal is that the tendon fibroblast surfaceome changes with development and the differing repertoire of proteins expressed regulates the stages of tendon formation. For aims 1 and 2, tendons from wild type PI mice will be used. At PI, tendons are predominantly in the earliest stage of formation (nucleation), where the fibroblast surface is crucial. Collagen V (Col V) and XI (Col XI) are expressed at the tendon fibroblast surface and interact there in the initiation of collagen fibril assembly. Aim 1 is to define the mechanism by which Col V and Col XI are associated with the fibroblast membrane and which specific proteins are responsible for tethering these collagens to the fibroblast membrane. Integrins and proteoglycans may be involved in the linkage of Col V and XI to the tendon fibroblast surface. The experimental design includes a Brij detergent extraction of the proteins from tendons, immunoprecipitation (IP) of Col V and XI and their associated proteins, and proteomic identification of these proteins. The data will be confirmed by localization of these candidate proteins in tendon extracts by (Western) blots and on the fibroblast surface by immunohistochemistry (IHC). Aim 2 is to identify the proteins that comprise the tendon fibroblast cell-surface and surface-associated (matrix) repertoire and that have roles in regulating tendon function. The surfaceome may also include molecules essential in signal transduction (such as FGF receptors), cell anchoring (such as adhesion molecules) and cell migration and matrix turnover (such as metalloproteinases). The proteins in the tendons will be extracted with Brij and identified by proteomics. Proteins identified in Aim 2 but not Aim 1 will be localized in extracts by blots and in tendons by IHC. Aim 3 is to define the developmental differences in the regulatory fibroblast surfaceome proteins identified in aims 1 and 2. Wild-type animals at 1-month (growing), 3-months (mature) and 18-months (aging) will be used. The candidate proteins from Aims 1 and 2 will be localized in tendon extracts from these animals by blots and in tendons by IHC. Knowing the regulatory proteins of developing tendons and their age-related changes allows better exploitation of the known regenerative capabilities of immature tendons. This will allow better clinical treatment and even reversal of debilitating tendon conditions in those with genetic tendon defects or who are aged or injured.
描述(申请人提供):这项建议将集中在肌腱成纤维细胞表面(肌腱成纤维细胞表面的蛋白质)及其在调节胶原纤维形成和细胞外基质(ECM)组装中的作用。纤维形成或装配的失调与肌肉骨骼疾病有关,如肌腱形成不当、肌腱炎症和损伤后肌腱愈合受损。这一建议的一般假设是,肌腱成纤维细胞表面体随着发育而变化,表达的不同蛋白质谱调控肌腱形成的不同阶段。对于AIMS 1和AIMS 2,将使用野生型PI小鼠的肌腱。在PI,肌腱主要处于形成的最早阶段(成核),成纤维细胞表面是至关重要的。V型胶原(Col V)和XI型胶原(Col XI)在肌腱成纤维细胞表面表达,并在胶原纤维组装的起始处相互作用。目的1是确定Col V和Col XI与成纤维细胞膜结合的机制,以及哪些特定蛋白负责将这些胶原连接到成纤维细胞膜上。整合素和蛋白多糖可能参与了胶原V和XI与肌腱成纤维细胞表面的连接。实验设计包括Brij洗涤剂提取肌腱中的蛋白质,免疫沉淀(IP)Col V和XI及其相关蛋白质,以及这些蛋白质的蛋白质组学鉴定。这些候选蛋白将通过(Western)blotts在肌腱提取液中的定位以及通过免疫组织化学(IHC)在成纤维细胞表面的定位来证实。目的2是确定组成肌腱成纤维细胞-细胞表面和表面相关(基质)谱系的蛋白质,并在肌腱功能调节中发挥作用。表面体还可以包括信号转导(如成纤维细胞生长因子受体)、细胞锚定(如黏附分子)、细胞迁移和基质转换(如金属蛋白酶)所必需的分子。肌腱中的蛋白质将用Brij提取,并通过蛋白质组学进行鉴定。在目标2而不是目标1中确定的蛋白质将通过斑点杂交定位于提取液中,并通过IHC定位于肌腱中。目的3是确定AIMS 1和AIMS 2中确定的调控成纤维细胞表面蛋白的发育差异。将使用1个月(生长)、3个月(成熟)和18个月(衰老)的野生型动物。AIMS 1和AIMS 2的候选蛋白将通过斑点定位于这些动物的肌腱提取液中,并通过IHC定位于肌腱中。了解发育中肌腱的调节蛋白及其与年龄相关的变化,可以更好地利用未成熟肌腱的已知再生能力。这将允许更好的临床治疗,甚至逆转那些有遗传性肌腱缺陷或年老或受伤的人虚弱的肌腱状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simone M-L Smith其他文献
Simone M-L Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simone M-L Smith', 18)}}的其他基金
Regulation of Tendon Extracellular Matrix Assembly by the Fibroblast Surfaceome
成纤维细胞表面组对肌腱细胞外基质组装的调节
- 批准号:
7915344 - 财政年份:2009
- 资助金额:
$ 5.3万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 5.3万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 5.3万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 5.3万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 5.3万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 5.3万 - 项目类别: